Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2025-04-01 00:00:00 ET · period of report 2025-04-01 · accession 0001415889-25-009369 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-01 | 2025-04-01 | FBIO | Jin David | CFO | A - Grant | $1.22 | +5,000 | 1.25M | +0.4% | +$6,100 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 | 2025-04-01 | A | A | 5,000 | $1.22 | 1,245,893 | D | — | — | (F1) The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). (F2) Total holdings include 1,230,000 shares underlying deferred restricted stock units. |